Recent reports indicate tumorigenicity and metastasis of ovarian cancer cells is significantly suppressed by the combination of HDAC inhibitor TSA and 5-Aza-dC in xenograft mouse models [78]. Here, HDAC9 is linked to ovarian cancer.